Genovior Biotech Corporation is a dedicated CDMO based in Taiwan, founded in 2015 by Dr. Steve J.P. Hsu, with more than 160 employees. The company focuses on process development, scale-up, formulation development, and productivity optimization under PIC/S GMP compliance. Genovior was acquired by Polaris Group and provides CDMO services for finished dosage form drugs.
CDMO services, formulation development, process development, scale-up, FDF drugs
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.